MARKER THERAPEUTICS, INC. Repayments of Related Party Debt
MARKER THERAPEUTICS, INC. (MRKR) reported Repayments of Related Party Debt of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-23.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfRelatedPartyDebt · last filed 2018-03-23
- MARKER THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2017-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2016-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. repayments of related party debt for the quarter ending 2015-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. repayments of related party debt for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- MARKER THERAPEUTICS, INC. repayments of related party debt for fiscal 2016 was $23.00K.
- MARKER THERAPEUTICS, INC. repayments of related party debt for fiscal 2015 was $0.00.
- MARKER THERAPEUTICS, INC. repayments of related party debt for fiscal 2013 was $30.87K.
| Period end | Repayments of Related Party Debt 3 month | Repayments of Related Party Debt 9 month | Repayments of Related Party Debt 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $0.00 10-K · filed 2018-03-23 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $23.00K 10-K · filed 2018-03-23 | |
| 2016-09-30 | $23.00K 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | $0.00 10-K · filed 2017-03-14 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | ||
| 2013-12-31 | $30.87K 10-K · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |